Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Endothelial dysfunction in hypertension: fact or fancy?

S Taddei¹, A Virdis, L Ghiadoni

¹Cattedra di Medicina Interna, Department of Internal Medicine, University of Pisa, Italy.

Journal of Cardiovascular Pharmacology

|January 12, 1999

Summary

Essential hypertension involves endothelial dysfunction, impairing nitric oxide (NO) availability. This dysfunction, linked to cyclo-oxygenase (COX) activation and oxidative stress, promotes atherosclerosis and thrombosis, necessitating therapies that restore NO function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025

Same author

PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)].

Cancer treatment reviews·2025

Same author

ANN uncertainty estimates in assessing fatty liver content from ultrasound data.

Computational and structural biotechnology journal·2024

Same author

Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020

Same author

THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS.

European journal of internal medicine·2020

Same author

Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells.

Human gene therapy·2019

Area of Science:

Cardiovascular Medicine
Vascular Biology
Hypertension Research

Background:

The endothelium plays a crucial role in regulating vascular tone and structure, primarily through nitric oxide (NO) production.
Endothelial dysfunction, characterized by impaired NO-mediated vasodilation, is a documented feature of human hypertension across various circulatory beds.
This dysfunction may be a primary phenomenon in essential hypertension, detectable early and not solely dependent on blood pressure levels.

Purpose of the Study:

To investigate the mechanisms underlying endothelial dysfunction in essential hypertension.
To explore the role of the cyclo-oxygenase (COX) pathway and oxidative stress in reducing nitric oxide (NO) availability.
To evaluate the potential of antihypertensive therapies to reverse endothelial dysfunction and restore NO function.

Related Experiment Videos

Main Methods:

Review of existing literature on endothelial function in hypertension.
Analysis of pathways involving nitric oxide (NO) and cyclo-oxygenase (COX) in endothelial cells.
Examination of the impact of antihypertensive agents on endothelial function and NO pathways.

Main Results:

Essential hypertension is associated with endothelial dysfunction, potentially driven by an alternative pathway involving cyclo-oxygenase (COX).
This COX pathway activation leads to oxidative stress, reducing nitric oxide (NO) availability and promoting vascular damage.
Dihydropyridine calcium antagonists show potential in restoring NO availability, possibly through antioxidant mechanisms.

Conclusions:

Endothelial dysfunction in essential hypertension is linked to reduced nitric oxide (NO) availability via COX pathway activation and oxidative stress.
Therapeutic strategies should aim not only to control blood pressure but also to restore endothelial function and NO bioavailability.
Dihydropyridine calcium antagonists may offer specific benefits by targeting the NO pathway and mitigating oxidative stress.